Changes are afoot to meet higher caseloads amid rising demand, the survey of 6,830 cardiovascular providers suggests.

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.

The national coverage determination explicitly outlines patient, clinician, and facilities criteria for qualifying procedures ...

Modern is consistent with the literature in this space, but the trial shows that a staged complete procedure might be just ...

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

The saphenous vein grafts treated in the RCT were relatively straightforward, while the native vessels were largely CTOs.

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after ...

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

Researchers hoped the technique might involve lower exposure compared with right transradial access, but this didn’t pan out.

The first of its kind RCT in acute intermediate-high-risk PE used a surrogate endpoint, but more data are on the horizon.

The rate of death or HF hospitalization was not influenced by the presence of leads after accounting for comorbidity burden.